We are live on ! Find out more
NYMX

Nymox Pharmaceutical Corp
NYMX

Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

39 hedge funds and large institutions have $590K invested in Nymox Pharmaceutical Corp in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less funds holding

Funds holding: 40 → 39 (-1)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

74% less capital invested

Capital invested by funds: $2.25M → $590K (-$1.66M)

83% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 12

90% less call options, than puts

Call options by funds: $1K | Put options by funds: $10K

Holders
39
Holders Change
-1
Holders Change %
-2.5%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
12
Closed
6
Calls
$1K
Puts
$10K
Net Calls
-$9K
Net Calls Change
-$7K

Top Buyers

Rank Fund Capital Flow
1
WAM
Warberg Asset Management
Illinois
+$23.8K
2
BHWM
Beaird Harris Wealth Management
Texas
+$22.4K
3
Renaissance Technologies
Renaissance Technologies
New York
+$18.2K
4
GVAG
Great Valley Advisor Group
Delaware
+$9.2K
5
BWA
BDO Wealth Advisors
Florida
+$4.32K

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$99K
2
M
Murchinson
Ontario, Canada
-$96K
3
DDC
DF Dent & Co
Maryland
-$94K
4
CH
CVI Holdings
Delaware
-$58K
5
MCM
MAI Capital Management
Ohio
-$44K
Name Holding Trade Value Shares
Change 		Change in
Stake
GVAG
26
Great Valley Advisor Group
Delaware
$4K +$9.2K +10,000 New
Osaic Holdings
27
Osaic Holdings
Arizona
$3K – – –
Simplex Trading
28
Simplex Trading
Illinois
$2K -$4.16K -4,523 -47%
BWA
29
BDO Wealth Advisors
Florida
$2K +$4.32K +4,700 New
Citigroup
30
Citigroup
New York
$1K -$99K -107,605 -99%
Bank of America
31
Bank of America
North Carolina
$1K -$5.66K -6,153 -65%
SIAP
32
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$1K – – –
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$696 -$92 -100 -6%
M
34
Murchinson
Ontario, Canada
– -$96K -76,404 Closed
DDC
35
DF Dent & Co
Maryland
– -$94K -75,000 Closed
CH
36
CVI Holdings
Delaware
– -$58K -45,993 Closed
Group One Trading
37
Group One Trading
Illinois
– -$33.2K -36,080 Closed
MCM
38
MAI Capital Management
Ohio
– -$44K -35,000 Closed
Citadel Advisors
39
Citadel Advisors
Florida
– -$15K -12,240 Closed
UBS Group
40
UBS Group
Switzerland
– +$345 +375 +68%
PA
41
PSI Advisors
Florida
– +$920 +1,000 New
1
2

NYMX Hedge Fund Activity: Q2 2022 in Review

39 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q2 2022, worth a combined $590K — down 74% from $2.25M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of NYMX and 5 opened new positions — a net loss of 1 holder — while 12 trimmed existing stakes and 2 added.

The largest buyer was Warberg Asset Management, adding an estimated $23.8K. The largest seller was Citigroup, cutting an estimated $99K.

  • 39 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q2 2022, down from 40 in Q1 2022.
  • Funds reported $590K of Nymox Pharmaceutical Corp stock for Q2 2022, down 74% quarter-over-quarter.
  • 5 funds opened new Nymox Pharmaceutical Corp positions in Q2 2022 and 6 closed out, a net change of -1 holder.
  • The largest Nymox Pharmaceutical Corp buyer in Q2 2022 was Warberg Asset Management, an estimated $23.8K added.
  • The largest Nymox Pharmaceutical Corp seller in Q2 2022 was Citigroup, an estimated $99K sold.

Based on aggregated 13F filings for Q2 2022.